Monika Tornsen
Directeur/Membre du Conseil chez IMMUNIC, INC.
Provenance du réseau au premier degré de Monika Tornsen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
17
| Subsidiary | Medical Specialties | 17 |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Biotechnology | 15 | |
| Public Company | Pharmaceuticals: Major | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Monika Tornsen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Founder Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel Sales & Marketing General Counsel | |
| 4SC AG | Biotechnology | Chairman Founder Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| SHIRE | Pharmaceuticals: Major | Public Communications Contact General Counsel Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SOLID BIOSCIENCES INC. | Biotechnology | Chief Operating Officer Chief Executive Officer | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Colorado Boulder | College/University | Undergraduate Degree Doctorate Degree | |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | President Corporate Officer/Principal | |
| Georgia State University | College/University | Graduate Degree Masters Business Admin | |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Biotechnology | Chief Operating Officer Chief Executive Officer | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| MEDCAP AB | Medical Specialties | Director/Board Member Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Investor | |
Indigo Diabetes NV
 Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member Director/Board Member | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
Fund+
 Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
DSM NV
 DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Chemicals: Specialty | Public Communications Contact Public Communications Contact | |
| Immunic Research GmbH | Chief Executive Officer Chief Executive Officer | ||
| PHARVARIS N.V. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Michigan | College/University | Masters Business Admin Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Sanofi-Synthélabo Ltd.
 Sanofi-Synthélabo Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 28 |
| Allemagne | 5 |
| France | 5 |
| Royaume-Uni | 4 |
| Belgique | 4 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 13 |
| Commercial Services | 3 |
| Finance | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 335 |
| Corporate Officer/Principal | 165 |
| Independent Dir/Board Member | 123 |
| Chairman | 61 |
| Chief Tech/Sci/R&D Officer | 53 |
Relations les plus connectées
| Insiders | |
|---|---|
| Tamar Howson | 41 |
| Tadataka Yamada | 36 |
| Jörg Neermann | 34 |
| Liam Ratcliffe | 32 |
| Michael Bonney | 32 |
| Elmar Schnee | 31 |
| Mary Gray | 27 |
| Renée Aguiar-Lucander | 26 |
| Eliseo Salinas | 22 |
| Vincent Ossipow | 22 |
| Fred Driscoll | 21 |
| Hilde Furberg | 21 |
| John Martin | 20 |
| David Meeker | 19 |
| Richard Peters | 16 |
- Bourse
- Insiders
- Monika Tornsen
- Connexions Sociétés
